The analysis of the gastroduodenal ulcerous bleeding relapse emergence risk factors
A treatment results retrospective analysis of 203 patients with ulcerous gastroduodenal bleeding was conducted, among them 135 (66,5%) are males and 68 (33,3%) are females. All patients were examined and provided with a conservative treatment according to protocols. Duodenal ulcer was diagnosed in 127 (62,56%) patients, gastric ulcer – in 68 (33,49%), gastroduodenal ulcer – in 9 (4,43%). The 24 (11,82%) patients had bleeding relapse, most of them (n=11 (45,83%) had it within 2-3 days upon arrival. The least number of relapses (4 (16,67%) cases) occurred within the first day. The most number of relapses (n=15 (62,5%) happened in patients without ulcerous anamnesis. A clear link between ulcer localization and relapse frequency was not determined. The 15 (62,5%) patients who had relapses were diagnosed with ІІ А class by Forrest. On the Glasgow Blatchford Score, 3 patients had relapses (12,5%) with 0 number of items, 11 (45,83%) – with up to 5 number of items, the other 10 (41,67%) – above 5 number of items. The relapses frequency grew up as the number of items on the Rockall Score, more cases occurred with 5-6 number of items patients (n=16 (66,67%), higher indicators appeared in separate cases. So, the Forrest, Glasgow Blatchford, Rockall Scores do not take into consideration the whole number of clinical and pathogenic factors of ulcerous bleeding relapse emergence. In order to optimize the efficiency bleeding prognosis, one has to take into account the factors complex that determine hemostasis and regeneration process condition.
2. Zaporozhan, S. Y. (2013). Prychyny nespryiatlyvykh rezultativ operatsiinoho likuvannia u khvorykh iz vyrazkovymy hastroduodenalnymy krovotechamy. Naukovyi visnyk Uzhhorodskoho universytetu. Ser.: Medytsyna, 2, 111–113. [in Ukrainian].
3. Petrushenko, V. V. & Hrebeniuk, D. I. (2014). Likuvalna taktyka pry hastroduodenalnykh krovotechakh vyrazkovoho henezu. Shpytalna khirurhiia, 1, 55–57. [in Ukrainian].
4. Matviichuk, B. O., Rachkevych, S. L. & Tumak, I. M. (2015). Prohnozuvannia retsydyvu vyrazkovykh krovotech pislia endoskopichnoho hemostazu. Acta medica Leopoliensia, 21(3), 53–58. [in Ukrainian].
5. Bereznytskyi, Ya. S., Boiko, V. V. & Vasylishyn, R. Y. (2010). Standarty orhanizatsii ta profesiino oriientovani protokoly nadannia medychnoi dopomohy khvorym z nevidkladnoiu khirurhichnoiu patolohiieiu orhaniv zhyvota. Kyiv: Zdorovia Ukrainy. [in Ukrainian].
6. Trofimov, M. V. Kryshen, V. P. & Muntian, S. O. (2016). Likuvalna taktyka pry shlunkovo-kyshkovii krovotechi vyrazkovoho genezu. Klinichna khirurhiia, 9, 11–13. [in Ukrainian].
7. Blatchford, O., Murray, W. R. & Blatchford, M. (2000). A risk score to predict need for treatment for uppergastrointestinal haemorrhage. The Lancet, 356(9238), 1318–1321.
8. Kim, B.S., Li, B.T. & Engel, A. (2014). Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World. J. Gastrointest. Pathophysiol., 5(4), 467–478.
9. Forrest, J. A. Finlayson, N. D. & Shearman, D. J. (1974). Endoscopy in gastrointestinal bleeding. The Lancet, 2, 7877, 394–397.
10. Kim, J. S. Park, S. M. & Kim, B. W. (2015). Endoscopic Management of Peptic Ulcer Bleeding. Clin. Endosc., 48(2), 106–111.
11. Rockall, T. A., Logan, R. F. A., Devlin, H. B. & Northfield, T. C. (1996). Risk assessment after acute upper gastrointestinal haemorrhage. Gut, 38(3), 316–321.
12. Cheng, H. C., Wu, C. T. & Chen, W. Y. (2016). Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion. Endosc. Int. Open, 4(3), 255–262.
13. Youn, Y. H., Park, Y. J. & Kim, J. H. (2012). Weekend and nighttime effect on the prognosis of peptic ulcer bleeding. World J. Gastroenterol., 18(27), 3578–3584.